Washington Report - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Washington Report

Manufacturers Look to Vaccines for Growth and Innovation

February 2, 2010

Pharmaceutical Technology

Vaccine R&D is surging, but continues to raise manufacturing and regulatory challenges.

Pharma Faces Multiple Challenges in the Year Ahead

January 2, 2010

Pharmaceutical Technology

Globalization and reform initiatves will shape pharma production, pricing, and pipelines in 2010.

Generic Drugs Come of Age

December 2, 2009

Pharmaceutical Technology

Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.

Safety versus Speed in Drug Development

November 2, 2009

Pharmaceutical Technology

The heightened focus on risk raises concerns about delays in approving new drugs.

New Leadership Seeks to Transform FDA

October 2, 2009

Pharmaceutical Technology

Strict enforcement, new rules, and organizational changes signal an activist tone.

Global Health Concerns Create Business Opportunities

September 2, 2009

Pharmaceutical Technology

Health crises generate support for new vaccines and treatments for diseases found in developing nations.

Pharma Girds for Healthcare Reform

August 2, 2009

Pharmaceutical Technology

Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.

Manufacturers Face New Risk-Management Requirements

July 2, 2009

Pharmaceutical Technology

REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.

FDA Waves a Big Stick

June 2, 2009

Pharmaceutical Technology

Agency officials and manufacturers anticipate stricter enforcement of drug safety and quality.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
When sourcing raw materials and non-GMP intermediates or other chemicals, where are the majority of your suppliers located?
In the United States
In Western Europe
In Central and Eastern Europe
In Japan
In India
In China
In the United States
20%
In Western Europe
18%
In Central and Eastern Europe
3%
In Japan
2%
In India
29%
In China
27%
View Results
Eric LangerOutsourcing OutlookEric Langer A Bio View of Outsourcing
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advances in Custom Synthesis
Faiz kermaniSpotlightFaiz Kermani Reinvigorating European R&D innovation
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
FindPharma Custom Search
Click here